Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Liabilities from Discontinued Operations (2022)

Bioventus' Liabilities from Discontinued Operations history spans 1 years, with the latest figure at 228911000.0 for Q4 2022.

  • For Q4 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 228911000.0; the TTM value through Dec 2022 reached 228911000.0, changed N/A, while the annual FY2022 figure was 228911000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations reached 228911000.0 in Q4 2022 per BVS's latest filing.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 228911000.0 in Q4 2022 to a low of 228911000.0 in Q4 2022.